Cargando…
Anti-malarial activity of a non-piperidine library of next-generation quinoline methanols
BACKGROUND: The clinical utility for mefloquine has been eroded due to its association with adverse neurological effects. Better-tolerated alternatives are required. The objective of the present study was the identification of lead compounds that are as effective as mefloquine, but exhibit physioche...
Autores principales: | Milner, Erin, McCalmont, William, Bhonsle, Jayendra, Caridha, Diana, Cobar, Jose, Gardner, Sean, Gerena, Lucia, Goodine, Duane, Lanteri, Charlotte, Melendez, Victor, Roncal, Norma, Sousa, Jason, Wipf, Peter, Dow, Geoffrey Stuart |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833169/ https://www.ncbi.nlm.nih.gov/pubmed/20149249 http://dx.doi.org/10.1186/1475-2875-9-51 |
Ejemplares similares
-
Central nervous system exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous dosing in mice
por: Dow, Geoffrey S, et al.
Publicado: (2011) -
Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds
por: Marcsisin, Sean R, et al.
Publicado: (2014) -
(R*,S*)-(±)-1-(2-{[2,8-Bis(trifluoromethyl)quinolin-4-yl](hydroxy)methyl}piperidin-1-yl)ethanone methanol monosolvate
por: Gonçalves, Raoni S. B., et al.
Publicado: (2011) -
Synthesis and biological evaluation of novel quinoline-piperidine scaffolds as antiplasmodium agents
por: Van de Walle, Tim, et al.
Publicado: (2020) -
(2-Chlorobenzo[h]quinolin-3-yl)methanol
por: Khan, F. Nawaz, et al.
Publicado: (2010)